Industry 4.0 stands for the automation and digitalization of traditional industrial processes through intelligent technologies and integration. Within this context, a "smart factory" is defined by machines that are interconnected and interoperable and can autonomously process data.
Both innovation and operational excellence are key pillars for Bachem's continued growth. Optimizing production is vital for us to support our customers in developing and manufacturing medicines. We have started our journey towards Industry 4.0 by automating and digitizing one of our core business processes, solid phase peptide synthesis (SPPS).
Thanks to automation, we can optimize plant utilization and reduce operating and staffing times to a fraction. This reduction enables an increase in production capacity (on a large scale), efficiency, and flexibility, resulting in more flexibility for new projects.
Featuring Patrizia Marchetti, Group Leader MSAT, Bachem
👉 More info here: www.bachem.com...
---------------------------------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Learn more about our products and services at bit.ly/3LykCeY
28 авг 2024
